Low-Fat Vegan Diet Reduced Liver Fat by 33 Percent in Clinical Trial

Trial Links Plant-Based Eating to Lower Liver Fat

A low-fat vegan diet reduced hepatocellular lipid levels by 33 percent over 16 weeks in adults with type 2 diabetes.

The study was conducted by investigators at the Physicians Committee for Responsible Medicine (PCRM) in collaboration with the Yale School of Medicine and published in BMJ Open Diabetes Research & Care. Participants followed the dietary intervention ad libitum, eating until full with no calorie counting or portion limits.

This project was the first dietary trial in type 2 diabetes to concurrently measure liver fat, muscle fat, visceral fat, and advanced glycation end products (AGEs).

Measurable Shifts in Weight and Pancreatic Function

Body weight dropped by an average of 6.0 kilograms (13.2 pounds), representing a 6.6 percent reduction from baseline.

Most of this shift came from a 4.2-kilogram (9.3-pound) loss of fat mass, alongside a 290-cubic-centimeter reduction in visceral abdominal fat volume. In addition, Hemoglobin A1c (HbA1c) fell by 1.0 percentage point across the cohort.

The trial also documented improvements in pancreatic beta-cell function across several objective clinical indices.

• Total cholesterol and low-density lipoprotein (LDL) cholesterol both decreased significantly.
• Markers of beta-cell function showed marked gains, including glucose-stimulated insulin secretion, beta-cell glucose sensitivity, rate sensitivity, and potentiation factor.
• Accumulation of tissue advanced glycation end products (AGEs), compounds associated with cellular damage in diabetes, dropped significantly.

Macronutrient Breakdown and Cellular Markers

The intervention centered on vegetables, whole grains, legumes, and fruit while keeping total dietary fat low.

The target macronutrient distribution supplied approximately 75 percent of calories from carbohydrates, 15 percent from protein, and 10 percent from fat. Participants received counseling to select these whole plant foods without weighing meals.

Laboratory measurements showed gains in insulin sensitivity indices such as Oral Glucose Insulin Sensitivity (OGIS) and PREdicted DIabetic Model (PREDIM), alongside a reduction in the homeostatic model assessment of insulin resistance (HOMA-IR).

Study Design and Interpretive Caveats

The trial used a 16-week single-arm design, which means it lacked an active control group following a conventional diabetes diet.

Because every participant received the same plant-based intervention, the data cannot separate the benefits of removing animal products from the metabolic effects of losing 6.0 kilograms of body weight. The participants also maintained a very low dietary fat threshold of 10 percent, which differs sharply from typical plant-based or Mediterranean eating patterns.

The 16-week intervention period reflects short-term outcomes, leaving long-term adherence and multi-year durability outside the scope of this publication.

Context for Managing Blood Sugar

Standard nutritional guidelines for type 2 diabetes frequently emphasize portion restriction and strict carbohydrate limits.

These trial results show that high-carbohydrate, low-fat whole foods can reduce hepatic lipid accumulation and lower average blood glucose without portion constraints.

Patients interested in altering their dietary macronutrient ratios should speak with their clinician to coordinate any necessary adjustments to diabetes medications.